🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs
5,427

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Page 111 of 114

  1. placebo

    Jazz Pharmaceuticals Ireland Limited

    Fibromyalgia

    phase 3 small molecule completed

    1 trial

  2. placebo (saline)

    Sanofi Pasteur

    Sphingomyelin Lipidosis

    phase 3 small molecule completed

    1 trial

  3. placebo for risankizumab

    AbbVie

    Crohn's Disease

    phase 3 small molecule completed

    1 trial

  4. placebo for risankizumab IV

    AbbVie

    Crohn's Disease

    phase 3 small molecule completed

    1 trial

  5. placebo ketamine inj prep, KETAMINE RENAUDIN 10 mg/ml, solution injectable

    ISTA Pharma Limited

    Traumatism

    phase 3 small molecule active

    1 trial

  6. placebo of metformine, METFORMINE VIATRIS 500 mg, comprimé dispersible

    Pari Pharma GmbH

    Myotonic dystrophy type 1 (DM1)

    phase 3 small molecule active

    1 trial

  7. placebo plus docetaxel

    Boehringer Ingelheim

    Carcinoma, Non-Small-Cell Lung

    phase 3 small molecule completed

    1 trial

  8. placebo to match albiglutide

    GlaxoSmithKline

    Diabetes Mellitus, Type 2

    phase 3 small molecule completed

    1 trial

  9. platelet-rich plasma combined with hyaluronic acid

    Hospital Authority, Hong Kong

    Traumatic Olfactory Nerve Injury With Anosmia (Diagnosis)

    phase 3 other active

    1 trial

  10. pneumococcal disease prevention

    Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

    Pneumococcal Vaccines

    phase 3 mab active

    1 trial

  11. poliovirus vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Poliomyelitis

    phase 3 mab completed

    1 trial

  12. postoperative antimicrobial prophylaxis

    Sun Yat-sen University

    Hepatocellular Carcinoma

    phase 3 small molecule on hold

    1 trial

  13. potassium citrate

    Ultragenyx UK Limited

    Hypercalciuria

    phase 3 small molecule completed

    1 trial

  14. pralatrexate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Refractory Peripheral T-Cell Lymphoma

    phase 3 small molecule completed

    1 trial

  15. prednisone

    Ultragenyx UK Limited

    Duchenne Muscular Dystrophy

    phase 3 small molecule completed

    1 trial

  16. prefilled liquid etanercept(Yisaipu)

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Ankylosing Spondylitis

    phase 3 small molecule completed

    1 trial

  17. pregabalin

    Pfizer

    Neuropathy

    phase 3 small molecule terminated

    1 trial

  18. pregabalin

    Pfizer

    Partial Seizures

    phase 3 small molecule completed

    2 trials

  19. preoperative short-course radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rectal Neoplasms

    phase 3 other terminated

    1 trial

  20. probiotic strain Bb-12

    United Therapeutics Europe Ltd

    Infections, Respiratory

    phase 3 other completed

    1 trial

  21. probiotics, antibiotics or antidepressants

    The First People's Hospital of Lianyungang

    Irritable Bowel Syndrome

    phase 3 small molecule active

    1 trial

  22. prucalopride

    Takeda

    Functional Constipation

    phase 3 small molecule completed

    1 trial

  23. rVA576

    Akari Therapeutics Plc

    Paroxysmal Nocturnal Hemoglobinuria

    phase 3 small molecule terminated

    1 trial

  24. rVA576

    Akari Therapeutics Plc

    Paroxysmal Nocturnal Hemoglobinuria (PNH)

    phase 3 small molecule completed

    1 trial

  25. rVWF

    Takeda

    Von Willebrand Disease (VWD)

    phase 3 mab completed

    1 trial

  26. radiation therapy

    United Therapeutics Europe Ltd

    Bladder Cancer

    phase 3 other completed

    1 trial

  27. ramucirumab

    Eli Lilly and Company

    Gastric Cancer

    phase 3 mab completed

    1 trial

  28. rasagiline

    Teva Pharma GmbH

    Restless Legs Syndrome

    phase 3 small molecule terminated

    1 trial

  29. recombinant human erythropoietin

    The First People's Hospital of Lianyungang

    Lymphoma

    phase 3 small molecule active

    1 trial

  30. recombinant human thrombopoietin

    The First People's Hospital of Lianyungang

    Immune Thrombocytopenia

    phase 3 small molecule active

    1 trial

  31. recombinant human thrombopoietin (rhTPO); dexamethasone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Purpura

    phase 3 small molecule completed

    1 trial

  32. recombinant human thrombopoietin (rhTPO); rituximab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Purpura

    phase 3 small molecule terminated

    1 trial

  33. recombinant interferon alfa

    United Therapeutics Europe Ltd

    Melanoma (Skin)

    phase 3 mab completed

    1 trial

  34. relacorilant

    CORCEPT THERAPEUTICS INC

    Cushing Syndrome

    phase 3 small molecule active

    2 trials

  35. relacorilant, CORT125134, Abraxane 5 mg/ml powder for dispersion for infusion.

    CORCEPT THERAPEUTICS INC

    Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer

    phase 3 small molecule active

    1 trial

  36. reslizumab

    Teva Pharma GmbH

    Eosinophilic Esophagitis

    phase 3 small molecule completed

    2 trials

  37. reslizumab

    Teva Pharma GmbH

    Eosinophils, Asthma

    phase 3 small molecule terminated

    1 trial

  38. rhIDU (recombinant human-Alpha-L-Iduronidase)

    BioMarin Pharmaceutical Australia Pty Ltd

    Mucopolysaccharidosis I

    phase 3 mab completed

    1 trial

  39. rhTPO

    The First People's Hospital of Lianyungang

    Immune Thrombocytopenia

    phase 3 small molecule active

    1 trial

  40. rhTPO

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Thrombocytopenia

    phase 3 small molecule active

    1 trial

  41. rhTPO in combination with Rituximab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Purpura

    phase 3 small molecule completed

    1 trial

  42. rifapentine

    Centers for Disease Control and Prevention

    Tuberculosis

    phase 3 small molecule completed

    2 trials

  43. riliprubart

    Sanofi-aventis Healthcare Pty Ltd

    Immune system diseases.

    phase 3 small molecule active

    1 trial

  44. riliprubart placebo, solution for injection in prefilled pen (PFP), riliprubart placebo, solution for injection in vial, riliprubart, riliprubart

    Sanofi-aventis Healthcare Pty Ltd

    Polyneuropathy, Inflammatory Demyelinating, Chronic

    phase 3 small molecule active

    1 trial

  45. riliprubart, -, riliprubart placebo solution for injection in prefilled pen, placebo matching IVIg, riliprubart, riliprubart placebo solution for injection in vial, -

    Sanofi-aventis Healthcare Pty Ltd

    Chronic Inflammatory Demyelinating Polyneuropathy

    phase 3 small molecule active

    1 trial

  46. rilonacept 160 mg

    Regeneron UK Limited

    Familial Cold Autoinflammatory Syndrome (FCAS)

    phase 3 small molecule completed

    1 trial

  47. risankizumab

    AbbVie

    Ulcerative Colitis (UC)

    phase 3 small molecule active

    1 trial

  48. risankizumab IV

    AbbVie

    Ulcerative Colitis (UC)

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.